Health Trials

Deep Versus Moderate Neuromuscular Blocking

ConditionsChange in Serum Levels of the Estimated Inflammatory CytokinesTotal Dose of IO FentanylPO MorphineSurgeons' RatingPain Scores
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorMenoufia University

About this trial

This study aimed for Determination of the impacts of deep neuromuscular blockade (DNMB) on surgical outcomes, consumption of perioperative opioid analgesia, and serum levels of inflammatory cytokines in comparison to moderate NMB (MNMB).

Eligibility criteria

Qualifiers

Women who will be admitted to undergo elective hysterectomy

Body mass index (BMI) of <35 kg/m2

Disqualifiers

the presence of neuromuscular disorders

uncontrolled medical diseases

autoimmune diseases, maintenance on immunosuppressant therapy for any indication

refusal to sign the written consent

Trial design

Treatments tested in this trial

  • Moderate Neuromuscular Blockade
  • Deep neuromuscular block

Treatment groups

88 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Faculty of Medicine Menoufia UniversityRecruiting32511, Menoufia, Eg.mnEgyptEgypt

Sponsors and collaborators

Menoufia University

Lead sponsor

Source ClinicalTrials.gov